VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.41
−4.15%Forward multiples
Based on analyst estimates
- P/E forward
- 0.74x
- P/E 2026E
- 1.34x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.71x
- PEG TTM
- 0.01x
- Price / book
- 1.13x
- Price / sales
- 0.38x
- Price / cash flow
- 2.74x
Enterprise value
- Enterprise value
- $37.0M
- EV / sales
- 0.15x
- EV / EBITDA
- 0.78x
- EV / EBIT
- 0.93x
- Market cap
- $93.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026